Protective immunity does not correlate with the hierarchy of virus- specific cytotoxic T cell responses to naturally processed peptides

Journal of Experimental Medicine

Volumn 187, Issue 10, 1998, Pages 1647-1657

  Gallimore, Awen ^a,c   Dumrese, Tilman ^b   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a   Rammensee, Hans Georg ^b  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Adoptive transfer; Antiviral protection; Cytotoxic T cell; Lymphocytic choriomeningitis virus; Peptide elution

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; VIRUS INFECTION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; IMMUNITY, CELLULAR; INTERFERON TYPE II; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032543212     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.10.1647     Document Type: Article

References (57)

1. Townsend, A., J. Rothbard, F.M. Gotch, G. Bahadur, D. Wraith, and A.J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44:959-968.
2. Maryanski, J.L., P. Pala, G. Corradin, B.R. Jordan, and J.C. Cerottini. 1986. H-2 restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature. 324:578-579.
3. Goldberg, A.L., and K.L. Rock. 1992. Proteolysis, proteosomes and antigen presentation. Nature. 357:375-379.
4. Dick, T., T. Ruppert, M. Groettrup, P. Kloetzel, L. Kuehn, U. Koszinowski, S. Stevanovic, H. Schild, and H. Rammensee. 1996. Coordinated dual cleavages induced by the proteosome regulator PA28 lead to dominant MHC ligands. Cell. 86:253-262.
5. Aki, M., N. Shimbara, M. Takashina, K. Akiyama, S. Kagawa, T. Tamura, M. Tanahashi, T. Yoshimura, K. Tanaka, and A. Ichihara. 1993. Interferon-γ induces different subunit organizations and functional diversity of proteosomes. J. Biochem. 115:257-269.
6. Gaczynska, M., K.L. Rock, and A.L. Goldberg. 1993. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteosomes. Nature. 365:264-267.
7. Drisscoll, J., M.G. Brown, D. Finley, and J.J. Monaco. 1993. MHC-linked LMP gene products specifically alter peptidase activities of the proteosome. Nature. 365:262-264.
8. Groettrup, M., A. Soza, M. Eggers, L. Kuehn, T.P. Dick, H. Schild, H.-G. Rammensee, U.H. Kosinowski, and P.-M. Kloetzel. 1996. A role for the proteosome regulator PA28α in antigen presentation. Nature. 381:166-168.
9. Androlewicz, M.J., K.S. Anderson, and P. Cresswell. 1993. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc. Natl. Acad. Sci. USA. 90:9130-9134.
10. Kelly, A., S.H. Powis, L.A. Kerr, I. Mockridge, T. Elliott, J. Bastin, Z.B. Uchanska, A. Ziegler, J. Trowsdale, and A. Townsend. 1992. Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature. 355:641-644.
11. Neefjes, J.J., F. Momburg, and G.J. Hammerling. 1993. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science. 261:769-771.
12. Shepherd, J.C., T.N.M. Schumacher, P.G. Ashton-Rickarcit, S. Imaeda, H.L. Ploegh, C.A. Janeway, and S. Tonegawa. 1993. TAP-1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell. 74:577-584.
13. Spies, T., V. Cerundolo, M. Colonna, P. Cresswell, A. Townsend, and R. DeMars. 1992. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature. 355:644-646.
14. Schumacher, T.N.M., D.V. Kantesaria, M.-T. Heemels, P.G. Ashton-Rickardt, J.C. Shepherd, K. Fruh, Y. Yang, P.A. Peterson, S. Tonegawa, and H.L. Ploegh. 1994. Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J. Exp. Med. 179:533-540.
15. Garrett, T., M.A. Saper, P.J. Bjorkman, J.L. Strominger, and D.C. Wiley. 1989. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature. 342:692-696.
16. Madden, D.R., J.C. Gorga, J.L. Strominger, and D.C. Wiley. 1992. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 70:1035-1048.
17. Silver, M.L., H.-C. Guo, J.L. Strominger, and D.C. Wiley. 1992. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature. 360:367-369.
18. Fremont, D.H., M. Matsumura, E.A. Stura, P.A. Peterson, and I.A. Wilson. 1992. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science. 257:919-927.
19. b molecule containing a single viral peptide: implications for peptide binding and T-cell recognition. Proc. Natl. Acad. Sci. USA. 89:8403-8407.
20. Falk, K., O. Roetzschke, S. Stevanovic, G. Jung, and H.G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 351:290-296.
21. Rammensee, H.-G. 1995. Chemistry of peptides associated with MHC class I and class II molecules. Curr. Opin. Immunol. 7:85-96.
22. Rammensee, H.-G., T. Friede, and S. Stefanoviic. 1995. MHC ligand motifs: first listing. Immunogenetics. 41:178-228.
23. b major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J. Virol. 69:2297-2305.
24. Klavinskis, L.S., J.L. Whitton, E. Joly, and M.B.A. Oldstone. 1990. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology. 178:393-400.
25. Pircher, H.P., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner, and R.M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 346:629-633.
26. Oldstone, M., J.L. Whitton, H. Lewicki, and A. Tishon. 1988. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes. J. Exp. Med. 168:559-570.
27. Hany, M., S. Oehen, M. Schulz, H. Hengartner, M. Mackett, D. Bishop, and R.M. Zinkernagel. 1989. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunisation with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur. J. Immunol. 19:417-424.
28. Whitton, J.L., P.J. Southern, and M.B.A. Oldstone. 1988. Analysis of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology. 162:321-327.
29. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science. 259:1742-1745.
30. Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10:1-173.
31. Romanowski, V., Y. Matsuura, and D. Bishop. 1985. Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of pichinde arenavirus. Virus Res. 3:101-114.
32. Salter, R.D., and P. Cresswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant T×B cell hybrid. EMBO (Eur. Mol. Biol. Organ.) J. 5:943-949.
33. Ohlen, C., J. Bastin, H.G. Ljunggren, S. Imreh, G. Klein, A.R. Townsend, and K. Kärre. 1990. Restoration of H-2b expression and processing of endogenous antigen in the MHC class I pathway by fusion of a lymphoma mutant to L cells of the H-2k haplotype. Eur. J. Immunol. 20:1873-1876.
34. Baenziger, J., H. Hengartner, R.M. Zinkernagel, and G.A. Cole. 1986. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur. J. Immunol. 16:387-393.
35. Zinkernagel, R.M., T.P. Leist, H. Hengartner, and A. Althage. 1985. Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J. Exp. Med. 162:2125-2141.
36. Bruns, M., J. Cihak, G. Müller, and F. Lehmann-Grube. 1983. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology. 130:247-251.
37. Lehmann-Grube, F., U. Assmann, C. Loliger, D. Moskophidis, and J. Lohler. 1985. Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. J. Immunol. 134:608-615.
38. Rötzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H.G. Rammensee. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature. 348:252-254.
39. Falk, K., O. Roetzschke, K. Deres, J. Metzger, G. Jung, and H.G. Rammensee. 1991. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 174:425-434.
40. Bishop, D.H.L. 1990. Arenaviruses and their replication. In Virology. 2nd ed. B.N. Fields, D.M. Knipe, R.M. Chanock, M.S. Hirsch, J.L. Melnick, T.P. Monath, and B. Roizman, editors. Raven Press, Ltd., New York. 1231-1267.
41. Alexander-Miller, M.A., G.R. Leggatt, and J.A. Berzofsky. 1996. Selective expansion of high-or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA. 93:4102-4107.
42. Ohashi, P.S., R.M. Zinkernagel, I. Leuscher, H. Hengartner, and H.P. Pircher. 1993. Enhanced positive selection of a transgenic TCR by a restriction element that does not permit negative selection. Int. Immunol. 5:131-138.
43. b molecules. Virology. 234:62-73.
44. b restricted cytotoxic T-cells. Eur. J. Immunol. 20:523-531.
45. Levitsky, V., Q.-J. Zhang, J. Levitskaya, and M.G. Masucci. 1996. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183:915-926.
46. Tsomides, T.J., A. Aldovini, R.P. Johnson, B.D. Walker, R.A. Young, and H.N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283-1293.
47. Pamer, E.G. 1994. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. J. Immunol. 152:686-694.
48. Vijh, S., and E.G. Pamer. 1997. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J. Immunol. 158:3366-3371.
49. Harding, C.V., and E.R. Unanue. 1990. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature. 346:574-576.
50. Demotz, S., H.M. Grey, and A. Sette. 1990. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science. 248:1028-1030.
51. Sykulev, Y., M. Joo, I. Vturina, T.J. Tsomides, and H.N. Eisen. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity. 4:565-571.
52. + memory T cells in virus-infected hosts. J. Exp. Med. 183:1367-1375.
53. + T cells are hyperreactive to antigenic challenge in vitro. J. Exp. Med. 184:2141-2151.
54. b major histocompatibility complex class I molecule to alloreactive T cells. J. Exp. Med. 182:1739-1750.
55. Valitutti, S., S. Müller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature. 375:148-151.
56. Valitutti, S., M. Dessing, K. Aktories, H. Gallati, and A. Lanzavecchia. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J. Exp. Med. 181:577-584.
57. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science. 273:104-106.